Amarex Clinical Research
28
6
6
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
25.0%
7 terminated/withdrawn out of 28 trials
61.1%
-25.4% vs industry average
4%
1 trials in Phase 3/4
73%
8 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
Role: collaborator
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
Role: collaborator
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
Role: collaborator
Clinical Pre-screening Protocol for Ovarian Cancer
Role: collaborator
Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC
Role: collaborator
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Role: collaborator
PRO 140 in Treatment-Experienced HIV-1 Subjects
Role: collaborator
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
Role: collaborator
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Role: collaborator
Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors
Role: collaborator
Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis
Role: collaborator
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Role: collaborator
Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19
Role: collaborator
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )
Role: collaborator
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma
Role: collaborator
A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation
Role: collaborator
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers
Role: collaborator
Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection
Role: collaborator
Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer
Role: collaborator
Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC
Role: collaborator